Normal function · from ai-gene-review (O00499, commit 79fe13b38970) · AI-generated, not KB evidence

BIN1 encodes amphiphysin II, a BAR/N-BAR and SH3-domain membrane-remodeling adaptor with extensive alternative splicing in brain and skeletal muscle. BIN1 binds phospholipid membranes, senses and generates membrane curvature, promotes lipid tubulation, and organizes membrane domains used in endocytosis, synaptic-vesicle cycling, endosomal sorting, and skeletal-muscle T-tubule formation. Through SH3-domain interactions with endocytic proteins such as dynamin and clathrin/AP2-associated machinery, BIN1 links curved membranes to vesicle trafficking and cytoskeletal organization. Additional context-specific functions include nuclear/MYC-related tumor-suppressor activities, tau and clusterin interactions, and regulation of BACE1 trafficking and amyloid-beta production.

BIN1 uses its N-BAR/BAR domain to bind phospholipid membranes, sense and generate membrane curvature, and drive membrane tubulation. This membrane-remodeling activity underlies T-tubule formation in skeletal muscle and curved membrane intermediates in endocytosis and endosomal trafficking.
BIN1 acts as an endocytic adaptor through SH3-domain and isoform-specific interactions with dynamin and clathrin/AP2-associated machinery, linking curved membrane domains to synaptic-vesicle cycling, endocytosis, and membrane trafficking.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Centronuclear Myopathy causative
mechanism: BIN1 amphiphysin-2 dysfunction
subtype: BIN1-CNM
scoped to subtype: BIN1-CNM
Alzheimer Disease untyped
Risk Factor
scoped to subtype: Late-Onset Alzheimer's Disease
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
centronuclear myopathy MONDO:0018947 AD Limited
2024-06-10
centronuclear myopathy MONDO:0018947 AR Definitive
2024-06-10

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.